(b)(4).(b)(6) 2022.The stem has been added to the complaint due to the report of elevated metal ions.The ra awareness date of the stem has been updated to (b)(6) 2022 to reflect receipt of the information.(b)(4) (b)(6) 2022.Additional information received through email from (b)(6) on (b)(6) 2022 at 7:06 am stating: can you please verify if metal ions levels were elevated? per dr.R yes.Was there any adverse symptoms experience by the patient that led to revision surgery? memory loss per dr.(b)(6) if yes, please provide details.Was there any deficiency with the depuy asr product? if yes, please provide details.None mentioned.Please provide the product number of the asr cup, head and sleeve.Scrub tech not able to identify product numbers.Kindly confirm if the stem was a depuy product.Yes.If yes, please provide the product and lot number.Stem retained.Not able to identify product numbers.Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
Product complaint # (b)(4).Investigation summary : no device associated with this report was received for examination.This hip replacement platform was voluntarily recalled from the market and the product codes are now considered inactive.Depuy considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation will be re-opened as necessary.Device history lot : device history reviews for asr platform have shown no indication of deviations or anomalies with regard to material, manufacturing or inspection.
|
Product complaint # (b)(4).Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|